Bristol-Myers Squibb | BMY - 운영 비용





운영 비용 변화 날짜
AbbVie USD 10.52B 258M 2026-09
Abbott USD 11.66B 1.2B 2026-09
ALKERMES USD 1.81B 57.02M 2026-06
Amgen USD 11.69B 6.9B 2026-06
AstraZeneca USD 11.55B 674M 2026-09
Biogen USD 2.32B 663.6M 2026-09
Bristol-Myers Squibb USD 23.4B 1.08B 2026-09
Coherus Biosciences USD 51.83M 2.48M 2025-12
Drreddys Laboratories INR 73.9B 431M 2026-09
Eli Lilly USD 10.52B 496M 2026-06
Gilead Sciences USD 13.04B 9.09B 2026-09
GlaxoSmithKline GBP 6.03B 227M 2026-09
J&J USD 18.93B 1.09B 2026-09
Medtronic USD 7.92B 203M 2026-06
Merck USD 10.75B 5.02B 2026-09
Novartis USD 9.88B 325M 2026-09
Novo Nordisk DKK 44.73B 7.52B 2026-06
Perrigo USD 290.5M 645.1M 2026-06
Pfizer USD 85.19B 4.91B 2026-06
Phibro Animal Health USD 361.83M 29.47M 2026-03
Prestige Brands USD 213.19M 7.06M 2026-06
Regeneron Pharmaceuticals USD 33.5B 1.79B 2026-09
Roche Holding CHF 18.9B 2.12B 2026-06
Sanofi EUR 10.51B 598M 2026-09
Sanofi EUR 9.92B 941M 2026-06
United Therapeutics USD 6.4B 499.2M 2026-06
Zoetis USD 3.15B 85M 2026-06